Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
Open Access
- 26 September 2013
- journal article
- Published by International Union of Crystallography (IUCr) in Journal of Synchrotron Radiation
- Vol. 20 (6) , 905-909
Abstract
Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the MK2–TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been observed for other Ser/Thr kinases. TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was determined at 2.0 Å resolution. Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2. In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2. However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position. In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favourable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2.Keywords
This publication has 26 references indexed in Scilit:
- Structure-based lead identification of ATP-competitive MK2 inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part IIBioorganic & Medicinal Chemistry Letters, 2010
- Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case studyBMC Structural Biology, 2009
- Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2Bioorganic & Medicinal Chemistry Letters, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUSStructure, 2003
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- Purification and Crystallization of Human Cyclin-dependent Kinase 2Journal of Molecular Biology, 1993
- Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinaseNature, 1991